Early laboratory results in mice show the drug PXS-5505 increases survival when combined with chemotherapy in the treatment of an aggressive form of pancreatic cancer.
As COVID finds its equilibrium, infection rates will rise and fall, influenced by seasons, school holidays and new subvariants. Managing the risk is complex and needs to be cost-effective.
Despite disruptions to testing and risk behaviour during COVID-19, the latest data from UNSW Sydney’s Kirby Institute shows Australia is tracking well towards the elimination of HIV transmission.
Receiving genetic health care can be a challenging, isolating experience for many people with intellectual disability. Meet the UNSW researchers who are trying to change that.